Goldfarb Branham LLP is investigating the buyout of Osteotech, Inc. (NASDAQ: OSTE) to determine whether its shareholders are receiving fair value in the $6.50 per share cash deal. Concerned shareholders are urged to contact securities lawyer Hamilton Lindley at 877-583-2855 or hlindley@goldfarbbranham.com to learn about their rights.

“In a recently filed lawsuit, shareholders that own approximately 24% of Osteotech's stock, state that they believe that the company has been underperforming because the Board of Directors has mismanaged Osteotech,” attorney Hamilton Lindley said. “Also, the deal is suspicious because the deal appears to be an attempt by the Company's Board of Directors to provide themselves with a defense to the lawsuit brought against them.”

Goldfarb Branham LLP attorneys have significant experience representing shareholders in unfair buyouts nationwide. The national securities firm provides nimble, creative and effective counsel at all stages of litigation. If you have information or concerns about this transaction, contact securities attorney Hamilton Lindley at the contact numbers listed below.

Grafico Azioni Osteotech Com (MM) (NASDAQ:OSTE)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Osteotech Com (MM)
Grafico Azioni Osteotech Com (MM) (NASDAQ:OSTE)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Osteotech Com (MM)